Company / Free Cash Flow per Share
Glaukos Corp. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.40
FY2025
5-year range
-$1.63 / -$0.40
FY2021-FY2025
Trend
+71.1%
vs FY2024
Sector context
#123 of 142
Health Care
What the data says
Glaukos Corp.'s free cash flow per share of $-0.40 is lower than 87% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.63 in FY2023 to $0.58 in FY2017.
Based on SEC 10-K filings.
-0.40 in FY2025.
Improved from $-1.63 to $-0.40 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 142This company -$0.40 Sector average $5.16
▼
-107.7% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 71.1% year-over-year.
- Ranks #123 out of 142 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.40 | +71.1% |
| FY2024 | -$1.38 | +15.7% |
| FY2023 | -$1.63 | -21.1% |
| FY2022 | -$1.35 | -164.5% |
| FY2021 | -$0.51 | +25.9% |
| FY2020 | -$0.69 | -387.7% |
| FY2019 | -$0.14 | -157.1% |
| FY2018 | $0.25 | -57.6% |
| FY2017 | $0.58 | +210.9% |
| FY2016 | $0.19 | +114.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026